Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026)
Syndax Pharmaceuticals' (SNDX) quarterly Revenue came in at $64.9 million in Q1 2026, up 223.64% year-on-year from $20.0 million in Q1 2025, and down 5.62% quarter-over-quarter from $68.7 million in Q4 2025.
Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Revenue history runs 10 years deep, the most recent figure standing at $64.9 million for Q1 2026.
- On a quarterly basis, Revenue rose 223.64% year-over-year to $64.9 million in Q1 2026; TTM through Mar 2026 was $217.4 million, a 397.28% increase from a year earlier, with the FY2025 full-year figure at $172.4 million, up 627.84% from the prior year.
- Revenue declined to $64.9 million in Q1 2026 per SNDX's latest filing, from $68.7 million in the prior quarter.
- Across five years, Revenue topped out at $68.7 million in Q4 2025 and bottomed at $3.5 million in Q2 2024.
- The 3-year median for Revenue is $29.0 million (2025), against an average of $32.6 million.
- Across the five-year window, Revenue soared 984.51% in 2025 and soared 223.64% in 2026, its largest moves.
- Year by year, Revenue stood at $7.7 million in 2024, then soared by 794.9% to $68.7 million in 2025, then dropped by 5.62% to $64.9 million in 2026.
- Per Business Quant, the three latest SNDX Revenue figures stand at $64.9 million (Q1 2026), $68.7 million (Q4 2025), and $45.9 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.85 Bn | 1.49 Bn | 53.02 Mn | 64.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.86 Mn |
| Dec 31, 2025 | 68.73 Mn |
| Sep 30, 2025 | 45.87 Mn |
| Jun 30, 2025 | 37.96 Mn |
| Mar 31, 2025 | 20.04 Mn |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Dec 31, 2021 | 126.58 Mn |
| Sep 30, 2021 | 12.38 Mn |
| Jun 30, 2021 | 379,000.00 |
| Mar 31, 2021 | 379,000.00 |
| Dec 31, 2020 | 380,000.00 |
| Sep 30, 2020 | 379,000.00 |
| Jun 30, 2020 | 379,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Sep 30, 2019 | 379,000.00 |
| Jun 30, 2019 | 379,000.00 |
| Mar 31, 2019 | 379,000.00 |